ClinicalTrials.Veeva

Menu

Optimal Analgesia in Acute Gastroenteritis

H

Hadassah Medical Center

Status and phase

Terminated
Phase 3

Conditions

Gastroenteritis

Treatments

Drug: Dipyrone
Drug: Papaverine

Study type

Interventional

Funder types

Other

Identifiers

NCT02711241
AGE123-HMO-CTIL

Details and patient eligibility

About

The purpose of this study is to find out an optimal way of analgesia in case of acute infectious gastroenteritis the investigators are going to compare two medicines that are used on everyday basis (without being ever before subject to scientifical study): Dipyrone and papaverine The study is done in the Emergency Department setting. Thus, only first 6 hours of treatment is included in study

Enrollment

15 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • acute gastroenteritis
  • VAS scale of pain perception at least 4

Exclusion criteria

  • pregnancy
  • allergy to any one of study preparations
  • blood pressure less than 85 on admission
  • surgical condition (acute abdomen) suspected or diagnosed

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

15 participants in 2 patient groups

Dipyrone
Active Comparator group
Treatment:
Drug: Dipyrone
Papaverine
Active Comparator group
Treatment:
Drug: Papaverine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems